Toggle light / dark theme

The personal genomics and biotechnology company 23andMe is perhaps best known for its home DNA testing kits, whereby consumers can learn about their genetic make-up or ancestry.

However, after the COVID-19 outbreak was declared a global pandemic, the company switched gears and looked to see how their gene testing services could offer a helping hand in understanding the disease’s pathophysiology.

One aspect of COVID-19 that has puzzled scientists and clinicians alike is why, when infected with SARS-CoV-2, do some patients display mild to moderate symptoms (or no symptoms at all), whereas other patients develop severe symptoms that can prove fatal?

Their new approach to 3D bioprinting and allows for non-invasive tissue growth and wound healing. It works through injecting bioink cells, the additive material traditionally used in 3D bioprinting, under the skin and using near-infrared light to penetrate the tissue and transfer customizable building designs — like an ear or an abstract shape — to newly injected cells.

The ear began to form in just 20 seconds.


Using a new approach to 3D bioprinting researchers have designed a way to non-invasively grow a wide range of customizable tissue under living skin.

Everyone knows that the great and power omnipresent mushroom that lives across the universe able to survive even in space.


Researchers have elucidated the molecular mechanism of the fungus that turns ants into living zombies. The fungus specifically affects the ants’ neurobiology, odor perception and biological clock. The Utrecht microbiologist Robin Ohm publishes this, together with American and German colleagues, in G3.

The Ophiocordyceps camponoti-floridani can infect and manipulate their in a way that is beneficial for fungus growth and transmission. These infected ants are called “zombie ants.” Influenced by the fungus, the ants climb to a high point and bite into a branch, attaching themselves until death. The fungus then digests the ant and forms a fruitbody with which the fungus spreads its spores. The behind this behavioral modification are still largely unknown, as in similar parasitic interactions in which the behavior of a host is manipulated.

“We can realistically recreate this interaction between the fungus and the ant in the lab. We have sequenced the genome of the fungus and determined all its . This gives us an important tool with which we can examine this system in detail,” says fungal researcher Robin Ohm of Utrecht University. “We then looked at the expression of all genes in the fungus and the ant during the behavioral modification. In this way, you get a good picture of the genes of both the fungus and the ant that may be involved in the behavioral modification.”

Guessing things are about to get dicey.


Texas reported a record-breaking number of COVID-19 hospitalizations Monday as the governor plans to reopen more businesses and double capacity.

Texas Department of State Health Services figures show 1,935 people were admitted as hospital patients for coronavirus-related treatment. That is up from a previous record of 1,888 on May 5.

The department’s new figures were released as Gov. Greg Abbott moves forward with a plan to open bars, restaurants, amusement parks and other businesses to 50% capacity.

Type: Novel lipid nanoparticle (LNP)-encapsulated mRNA vaccine encoding for a prefusion stabilized form of the Spike (S) protein.

Status: Moderna said May 29 the first patients in both cohorts were dosed in the company’s Phase II trial (NCT04405076) assessing mRNA-1273. The study is designed to evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273, given 28 days apart. plans to enroll 600 healthy participants across two cohorts: 300 adults ages 18–55 years, and 300 ages 55 years and up. Participants will be assigned to placebo, a 50 μg or a 100 μg dose at both vaccinations, and will be followed through 12 months after the second vaccination.